Minimal residual disease by circulating tumor DNA analysis for colorectal cancer patients receiving radical surgery: An initial report from CIRCULATE-Japan.

Hiroki Yukami,Yoshiaki Nakamura,Jun Watanabe,Masahito Kotaka,Kentaro Yamazaki,Keiji Hirata,Yasunori Emi,Mitsuru Yokota,Kentaro Kato,Tatsuro Yamaguchi,Masataka Ikeda,Alexey Aleshin,Daisuke Kotani,Saori Mishima,Hiromichi Shirasu,Eiji Oki,Ichiro Takemasa,Takeshi Kato,Hiroya Taniguchi,Takayuki Yoshino

Minimal residual disease by circulating tumor DNA analysis for colorectal cancer patients receiving radical surgery: An initial report from CIRCULATE-Japan.

2021

3608Background: Circulating tumor DNA (ctDNA) analysis can be used to predict the risk of recurrence by detecting molecular residual disease (MRD) in patients with colorectal cancer (CRC). We are c...

Keywords:

Medicine
Internal medicine
Colorectal cancer
in patient
Disease
Oncology
Radical surgery
Minimal residual disease
Circulating tumor DNA

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations